Amedeo Smart

Free Medical Literature Service


 

Amedeo

Liver Diseases

  Free Subscription

Articles published in
Radiology
    June 2025
  1. ADAMO RG, van der Pol CB, Alabousi M, Lam E, et al
    Diagnostic Performance of CT/MRI LI-RADS Version 2018 Major Feature Combinations: Individual Participant Data Meta-Analysis.
    Radiology. 2025;315:e243450.
    >> Share

    May 2025
  2. LIU H, Fan W, Li H, Qiao L, et al
    Idarubicin versus Epirubicin in Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma: An Open-label, Randomized, Phase IV Trial.
    Radiology. 2025;315:e242315.
    >> Share

    April 2025
  3. WU H, Zhu Z, Li J, Qiu C, et al
    Three-Dimensional Vector MR Elastography for Evaluating Tissue Mechanical Heterogeneity to Assess Liver Disease Progression.
    Radiology. 2025;315:e242349.
    >> Share

  4. QIU C
    US Markers for Differentiating Hepatic Inflammation in Chronic Liver Disease: Still a Long Way to Go.
    Radiology. 2025;315:e242559.
    >> Share

  5. GUO X, Zhou Y
    Agenesis of the Intrahepatic Inferior Vena Cava with Pulmonary Venous Fistula.
    Radiology. 2025;315:e242069.
    >> Share

    March 2025
  6. LEE S, Yoon JK, Shin J, Shin H, et al
    US Liver Imaging Reporting and Data System Version 2017: A Systematic Review and Meta-Analysis.
    Radiology. 2025;314:e240450.
    >> Share

  7. DELL T, Mesropyan N, Layer Y, Tischler V, et al
    Photon-counting CT-derived Quantification of Hepatic Fat Fraction: A Clinical Validation Study.
    Radiology. 2025;314:e241677.
    >> Share

  8. REA B, Blakeborough A
    Case 339.
    Radiology. 2025;314:e242717.
    >> Share

  9. AN J, Park R, Kim E, Na SK, et al
    LI-RADS for Diagnosing Hepatocellular Carcinoma in Patients with Noncirrhotic Chronic Hepatitis C.
    Radiology. 2025;314:e241856.
    >> Share

  10. SCHOLLNAST H
    Imaging-based Hepatocellular Carcinoma Diagnosis: An Extension of LI-RADS to Patients with Noncirrhotic Hepatitis C.
    Radiology. 2025;314:e250627.
    >> Share

    February 2025
  11. ZHANG YJ, Chen J, Zhou Z, Hu D, et al
    Transarterial Chemoembolization with Radiofrequency Ablation versus Surgical Resection for Small Late-Recurrence Hepatocellular Carcinoma.
    Radiology. 2025;314:e241096.
    >> Share

  12. ZHANG K, He K, Zhang L, Li WC, et al
    Gadoxetic Acid-enhanced MRI Scoring Model to Predict Pathologic Features of Hepatocellular Carcinoma.
    Radiology. 2025;314:e233229.
    >> Share

  13. RONOT M
    Advancing Care: Managing Small Late-Recurrence Hepatocellular Carcinoma with Image-guided Therapy.
    Radiology. 2025;314:e243768.
    >> Share

  14. BITAR R, Salem R, Finn R, Greten TF, et al
    Erratum for: Interventional Oncology Meets Immuno-oncology: Combination Therapies for Hepatocellular Carcinoma.
    Radiology. 2025;314:e259004.
    >> Share

    January 2025
  15. WILDMAN-TOBRINER B, Felice N, Kalisz KR, Allen BC, et al
    Photon-Counting CT Effects on Sensitivity for Liver Lesion Detection: A Reader Study Using Virtual Imaging.
    Radiology. 2025;314:e241568.
    >> Share

  16. LYSHCHIK A, Kuon Yeng Escalante C, Siu Xiao T, Piscaglia F, et al
    Contrast-enhanced US of High-Risk Indeterminate Focal Liver Observations Categorized as LR-4 or LR-M at CT/MRI.
    Radiology. 2025;314:e240916.
    >> Share

  17. LI W, Lv J, Li H, Song L, et al
    Quantification of Vascular Remodeling and Sinusoidal Capillarization to Assess Liver Fibrosis with Photoacoustic Imaging.
    Radiology. 2025;314:e241275.
    >> Share

    December 2024
  18. KAMAYA A, Fetzer DT, Seow JH, Burrowes DP, et al
    LI-RADS US Surveillance Version 2024 for Surveillance of Hepatocellular Carcinoma: An Update to the American College of Radiology US LI-RADS.
    Radiology. 2024;313:e240169.
    >> Share

  19. JANG HJ, Choi SH, Wee S, Choi SJ, et al
    CT- and MRI-based Factors Associated with Rapid Growth in Early-Stage Hepatocellular Carcinoma.
    Radiology. 2024;313:e240961.
    >> Share

    November 2024
  20. HAGHSHOMAR M, Antonacci D, Smith AD, Thaker S, et al
    Diagnostic Accuracy of CT for the Detection of Hepatic Steatosis: A Systematic Review and Meta-Analysis.
    Radiology. 2024;313:e241171.
    >> Share

  21. JIANG H, Cannella R, Wu Z, Beaufrere A, et al
    Prognostic Implications of MRI-assessed Intratumoral Fat in Hepatocellular Carcinoma: An Asian and European Cohort Study.
    Radiology. 2024;313:e233471.
    >> Share

  22. HARMATH C
    Hepatocellular Carcinoma: The Meaning of Intratumoral Fat Patterns in Different Patient Populations.
    Radiology. 2024;313:e242740.
    >> Share

  23. LAI B, Zhong J
    Hepatic Langerhans Cell Histiocytosis.
    Radiology. 2024;313:e241037.
    >> Share

  24. ASLAM A, Chernyak V, Miller FH, Bashir M, et al
    CT/MRI LI-RADS 2024 Update: Treatment Response Assessment.
    Radiology. 2024;313:e232408.
    >> Share

  25. BITAR R, Salem R, Finn R, Greten TF, et al
    Interventional Oncology Meets Immuno-oncology: Combination Therapies for Hepatocellular Carcinoma.
    Radiology. 2024;313:e232875.
    >> Share

    October 2024
  26. RIEDEL C, Hoffmann M, Ismahil M, Lenz A, et al
    Four-dimensional Flow MRI-based Computational Fluid Dynamics Simulation for Noninvasive Portosystemic Pressure Gradient Assessment in Patients with Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt.
    Radiology. 2024;313:e232989.
    >> Share

  27. MATOS C, Metens T
    Liver Fibrosis: Diving into Microstructure with Diffusion-weighted Imaging.
    Radiology. 2024;313:e242548.
    >> Share

  28. ZHANG L, Long X, Chen L, Han X, et al
    Detecting Cellular Microstructural Changes of Liver Fibrosis with Time-Dependent Diffusion MRI.
    Radiology. 2024;313:e240343.
    >> Share

  29. CAO J, Mroueh N, Mercaldo N, Lennartz S, et al
    Detectability of Hypoattenuating Liver Lesions with Deep Learning CT Reconstruction: A Phantom and Patient Study.
    Radiology. 2024;313:e232749.
    >> Share

  30. MOTOSUGI U, Watanabe H
    Navigating Hemodynamic Insights: A Promising Future with Four-dimensional Flow MRI and Computational Fluid Dynamics in Transjugular Intrahepatic Portosystemic Shunt Management.
    Radiology. 2024;313:e241857.
    >> Share

  31. FERRAIOLI G, Roccarina D, Barr RG
    Intersystem and Interoperator Agreement of US Attenuation Coefficient for Quantifying Liver Steatosis.
    Radiology. 2024;313:e240162.
    >> Share

    September 2024
  32. MENDIRATTA-LALA M, Wiggermann P, Pech M, Serres-Creixams X, et al
    The #HOPE4LIVER Single-Arm Pivotal Trial for Histotripsy of Primary and Metastatic Liver Tumors.
    Radiology. 2024;312:e233051.
    >> Share

  33. PIERCE TT, Ozturk A, Sherlock SP, Moura Cunha G, et al
    Reproducibility and Repeatability of US Shear-Wave and Transient Elastography in Nonalcoholic Fatty Liver Disease.
    Radiology. 2024;312:e233094.
    >> Share

  34. AHMED TM, Fishman EK
    Cinematic Rendering of Hepatic Hydatid Disease.
    Radiology. 2024;312:e240527.
    >> Share

  35. WILDMAN-TOBRINER B
    Photon-counting Detector CT: A Promising Tool for Noninvasive Liver Fat Assessment.
    Radiology. 2024;312:e241963.
    >> Share

  36. LIN H, Xu X, Deng R, Xu Z, et al
    Photon-counting Detector CT for Liver Fat Quantification: Validation across Protocols in Metabolic Dysfunction-associated Steatotic Liver Disease.
    Radiology. 2024;312:e240038.
    >> Share

    August 2024
  37. SUGIMOTO K, Moriyasu F, Dioguardi Burgio M, Vilgrain V, et al
    US Markers and Necroinflammation, Steatosis, and Fibrosis in Metabolic Dysfunction-associated Steatotic Liver Disease: The iLEAD Study.
    Radiology. 2024;312:e233377.
    >> Share

  38. YIN M
    Shear-Wave Dispersion for Detecting Hepatic Inflammation in Metabolic Dysfunction-associated Steatotic Liver Disease.
    Radiology. 2024;312:e241420.
    >> Share

  39. CHEUNG CL, Tripathi V, Chiang CL, Chiu KWH, et al
    Impact of Hepatocellular Carcinoma Etiology on the Performance of LI-RADS LR5.
    Radiology. 2024;312:e240056.
    >> Share

    June 2024
  40. KIM PH, Hwang JY, Choi YH, Yoon HM, et al
    Safety of Gadoxetate Disodium for Hepatobiliary MRI in Children and Adolescents.
    Radiology. 2024;311:e232462.
    >> Share

  41. OTERO HJ
    Gadoxetate Disodium Hepatobiliary Contrast Material Is Safe in Children and Adolescents.
    Radiology. 2024;311:e241082.
    >> Share

    May 2024
  42. SARWAR A, Malik MS, Vo NH, Tsai LL, et al
    Efficacy and Safety of Radiation Segmentectomy with (90)Y Resin Microspheres for Hepatocellular Carcinoma.
    Radiology. 2024;311:e231386.
    >> Share

  43. MENDIRATTA-LALA M, Fetzer D, Kamaya A, Parikh ND, et al
    The Future Role of Abdominal US in Hepatocellular Carcinoma Surveillance.
    Radiology. 2024;311:e232624.
    >> Share

  44. OZKAYA E, Kennedy P, Chen J, Bane O, et al
    Precision and Test-Retest Repeatability of Stiffness Measurement with MR Elastography: A Multicenter Phantom Study.
    Radiology. 2024;311:e233136.
    >> Share

  45. TANG A
    Liver Stiffness at MR Elastography: A Surrogate Biomarker for Staging Liver Fibrosis, Predicting Clinical Outcomes, and Selecting Patients.
    Radiology. 2024;311:e240890.
    >> Share

  46. MILOT L
    Hepatocellular Carcinoma Assessment after Locoregional Treatment: A Primer on LI-RADS Contrast-Enhanced Nonradiation Treatment Response Assessment Version 2024.
    Radiology. 2024;311:e240124.
    >> Share

  47. LYSHCHIK A, Fetzer DT, Kono Y, Wilson SR, et al
    Liver Imaging Reporting and Data System Contrast-Enhanced US Nonradiation Treatment Response Assessment Version 2024.
    Radiology. 2024;311:e232369.
    >> Share

    April 2024
  48. YOON JH, Kim YK, Kim JW, Chang W, et al
    Comparison of Four Diagnostic Guidelines for Hepatocellular Carcinoma Using Gadoxetic Acid-enhanced Liver MRI.
    Radiology. 2024;311:e233114.
    >> Share

  49. LEE Y, Kim NH, Kang JH, Cho YS, et al
    Validation of Diagnostic Thresholds for Compensated Advanced Chronic Liver Disease Using Supersonic Shear Imaging.
    Radiology. 2024;311:e232188.
    >> Share

  50. LYU L, Xu P
    Hepatic CT Perfusion in Budd-Chiari Syndrome before and after Intervention.
    Radiology. 2024;311:e232426.
    >> Share

  51. GHOSH A
    B-mode US and Deep Learning Rivals Shear-Wave Elastography in Screening for Fibrosis.
    Radiology. 2024;311:e240868.
    >> Share

  52. ZENG QQ, Liang P
    Super-Resolution US Imaging of Focal Nodular Hyperplasia.
    Radiology. 2024;311:e233130.
    >> Share

  53. CHEN LD, Huang ZR, Yang H, Cheng MQ, et al
    US-based Sequential Algorithm Integrating an AI Model for Advanced Liver Fibrosis Screening.
    Radiology. 2024;311:e231461.
    >> Share

    March 2024
  54. MOURA CUNHA G, Fan B, Navin PJ, Olivie D, et al
    Interpretation, Reporting, and Clinical Applications of Liver MR Elastography.
    Radiology. 2024;310:e231220.
    >> Share

  55. LIU F, Bi M, Jing X, Ding H, et al
    Multiparametric US for Identifying Metabolic Dysfunction-associated Steatohepatitis: A Prospective Multicenter Study.
    Radiology. 2024;310:e232416.
    >> Share

  56. REUTER KL
    Noninvasive Identification of Metabolic Dysfunction-associated Steatohepatitis Globally.
    Radiology. 2024;310:e240436.
    >> Share

    February 2024
  57. CHAPIRO J
    Image-guided High-Dose-Rate Brachytherapy for Hepatocellular Carcinoma Could Be the Ultimate Ablation Tool.
    Radiology. 2024;310:e240072.
    >> Share

  58. AUER TA, Muller L, Schulze D, Anhamm M, et al
    CT-guided High-Dose-Rate Brachytherapy versus Transarterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma.
    Radiology. 2024;310:e232044.
    >> Share

  59. SHEWAREGA A, Santana JG, Nam D, Berz A, et al
    Effect of Incomplete Cryoablation and Matrix Metalloproteinase Inhibition on Intratumoral CD8(+) T-Cell Infiltration in Murine Hepatocellular Carcinoma.
    Radiology. 2024;310:e232365.
    >> Share

  60. GEMMETE JJ
    Partial Cryoablation and Matrix Metalloproteinase Inhibition May Be a Possible Treatment Option for Hepatocellular Carcinoma.
    Radiology. 2024;310:e240015.
    >> Share

  61. CRIVELLARO P
    A Deeper Look into Ancillary Features in LI-RADS Classification.
    Radiology. 2024;310:e240251.
    >> Share

  62. DAWIT H, Lam E, McInnes MDF, van der Pol CB, et al
    LI-RADS CT and MRI Ancillary Feature Association with Hepatocellular Carcinoma and Malignancy: An Individual Participant Data Meta-Analysis.
    Radiology. 2024;310:e231501.
    >> Share

  63. CANNELLA R, Matteini F, Dioguardi Burgio M, Sartoris R, et al
    Association of LI-RADS and Histopathologic Features with Survival in Patients with Solitary Resected Hepatocellular Carcinoma.
    Radiology. 2024;310:e231160.
    >> Share

  64. KARTALIS N, Grigoriadis A
    LI-RADS in Patients with Solitary Resected Hepatocellular Carcinoma: Glancing beyond Diagnosis.
    Radiology. 2024;310:e240161.
    >> Share

    January 2024
  65. MA L, Zhang W, Ma J, Luo J, et al
    Transjugular Intrahepatic Portosystemic Shunt versus Endoscopy with Drug Therapy Warrants Further Exploration.
    Radiology. 2024;310:e232499.
    >> Share

  66. TAN XZ, Chen X, Liu P
    Potential Influence of Inconsistent Arterial Phase Imaging on Macrotrabecular-massive Hepatocellular Carcinoma Prediction.
    Radiology. 2024;310:e232349.
    >> Share

  67. KADI D, Loomba R, Bashir MR
    Diagnosis and Monitoring of Nonalcoholic Steatohepatitis: Current State and Future Directions.
    Radiology. 2024;310:e222695.
    >> Share

  68. FOWLER KJ, Chernyak V
    What Is in a Name: Understanding the Nomenclature Updates for Fatty Liver Disease.
    Radiology. 2024;310:e232771.
    >> Share

  69. DIETRICH CF
    Modified Algorithm for Contrast-enhanced US LI-RADS.
    Radiology. 2024;310:e232742.
    >> Share

    December 2023
  70. GOINS SM, Jiang H, van der Pol CB, Salameh JP, et al
    Individual Participant Data Meta-Analysis of LR-5 in LI-RADS Version 2018 versus Revised LI-RADS for Hepatocellular Carcinoma Diagnosis.
    Radiology. 2023;309:e231656.
    >> Share

  71. SIRLIN CB, Chernyak V
    Are We Ready to Simplify and Improve LI-RADS?
    Radiology. 2023;309:e233164.
    >> Share

  72. TAMIR S, Tau N
    Hepatocellular Carcinoma and Pretransplant Liver Imaging: Benefits of Per-patient Assessment.
    Radiology. 2023;309:e233123.
    >> Share

  73. HASSAN OT, Behr SC, Ohliger MA, Fowler KJ, et al
    Per-patient Negative Predictive Value of the CT and MRI Liver Imaging Reporting and Data System Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma.
    Radiology. 2023;309:e222776.
    >> Share

    November 2023
  74. JIANG H, Yang C, Chen Y, Wang Y, et al
    Development of a Model including MRI Features for Predicting Advanced-stage Recurrence of Hepatocellular Carcinoma after Liver Resection.
    Radiology. 2023;309:e230527.
    >> Share

  75. HSIEH C, Laguna A, Ikeda I, Maxwell AWP, et al
    Using Machine Learning to Predict Response to Image-guided Therapies for Hepatocellular Carcinoma.
    Radiology. 2023;309:e222891.
    >> Share

  76. TSAI R, Mellnick VM
    Using an Imaging Model to Predict Recurrence in Patients with Hepatocellular Carcinoma.
    Radiology. 2023;309:e232480.
    >> Share

  77. OZTURK A, Kumar V, Pierce TT, Li Q, et al
    The Future Is Beyond Bright: The Evolving Role of Quantitative US for Fatty Liver Disease.
    Radiology. 2023;309:e223146.
    >> Share

  78. TAN XZ, Liu P, Xiang H
    The Influence of Single Arterial Phase Imaging on Prediction of Microvascular Invasion of Hepatocellular Carcinoma.
    Radiology. 2023;309:e231141.
    >> Share

    October 2023
  79. TUTHILL TA
    Advancing AI-assisted US Screening for Fatty Liver.
    Radiology. 2023;309:e232442.
    >> Share

  80. HAN A
    Hepatic Steatosis Assessment: Harnessing the Power of Integrating Multiple Quantitative US Parameters.
    Radiology. 2023;309:e232475.
    >> Share

  81. VIANNA P, Calce SI, Boustros P, Larocque-Rigney C, et al
    Comparison of Radiologists and Deep Learning for US Grading of Hepatic Steatosis.
    Radiology. 2023;309:e230659.
    >> Share

  82. KURODA H, Oguri T, Kamiyama N, Toyoda H, et al
    Multivariable Quantitative US Parameters for Assessing Hepatic Steatosis.
    Radiology. 2023;309:e230341.
    >> Share

  83. SAVSANI E, Shaw CM, Forsberg F, Wessner CE, et al
    Contrast-enhanced US Evaluation of Hepatocellular Carcinoma Response to Chemoembolization: A Prospective Multicenter Trial.
    Radiology. 2023;309:e230727.
    >> Share

  84. HEO S, Lee SS, Choi SH, Kim DW, et al
    CT Rule-in and Rule-out Criteria for Clinically Significant Portal Hypertension in Chronic Liver Disease.
    Radiology. 2023;309:e231208.
    >> Share

  85. FRAUM TJ
    CT-based Diagnosis of Clinically Significant Portal Hypertension: An Opportunity to Prevent Complications.
    Radiology. 2023;309:e232439.
    >> Share

  86. XIA T, Du M, Li H, Wang Y, et al
    Association between Liver MRI Proton Density Fat Fraction and Liver Disease Risk.
    Radiology. 2023;309:e231007.
    >> Share

  87. REEDER SB, Starekova J
    MRI Proton Density Fat Fraction for Liver Disease Risk Assessment: A Call for Clinical Implementation.
    Radiology. 2023;309:e232552.
    >> Share

  88. MONSELL SE
    Statistical Methods for Exploring Causal Relationships between Risk Factors and Liver Disease.
    Radiology. 2023;309:e232551.
    >> Share

  89. FOWLER KJ, Venkatesh SK, Obuchowski N, Middleton MS, et al
    Repeatability of MRI Biomarkers in Nonalcoholic Fatty Liver Disease: The NIMBLE Consortium.
    Radiology. 2023;309:e231092.
    >> Share

  90. KOZAKA K, Matsui O
    MRI Biomarkers and Their Future Impact on Nonalcoholic Fatty Liver Disease.
    Radiology. 2023;309:e232420.
    >> Share

    September 2023
  91. HYODO R, Takehara Y, Mizuno T, Ichikawa K, et al
    Four-dimensional Flow MRI Assessment of Portal Hemodynamics and Hepatic Regeneration after Portal Vein Embolization.
    Radiology. 2023;308:e230709.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016